Protagenic Retained Earnings vs Short Long Term Debt Total Analysis

PTIX Stock  USD 0.44  0.01  2.22%   
Protagenic Therapeutics financial indicator trend analysis is much more than just breaking down Protagenic Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protagenic Therapeutics is a good investment. Please check the relationship between Protagenic Therapeutics Retained Earnings and its Short Long Term Debt Total accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.

Retained Earnings vs Short Long Term Debt Total

Retained Earnings vs Short Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Protagenic Therapeutics Retained Earnings account and Short Long Term Debt Total. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Protagenic Therapeutics' Retained Earnings and Short Long Term Debt Total is -0.48. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of Protagenic Therapeutics, assuming nothing else is changed. The correlation between historical values of Protagenic Therapeutics' Retained Earnings and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Protagenic Therapeutics are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Retained Earnings i.e., Protagenic Therapeutics' Retained Earnings and Short Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

-0.48
Relationship DirectionNegative 
Relationship StrengthVery Weak

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Short Long Term Debt Total

Most indicators from Protagenic Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protagenic Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.Selling General Administrative is likely to drop to about 1 M in 2025. Sales General And Administrative To Revenue is likely to drop to 0.19 in 2025
 2022 2023 2024 2025 (projected)
Reconciled Depreciation30.01.6K1.9K2.0K
Interest Income185.8K303.2K348.7K366.2K

Protagenic Therapeutics fundamental ratios Correlations

-0.350.09-0.090.64-0.18-0.33-0.030.22-0.19-0.190.99-0.240.56-0.250.68-0.07-0.110.96-0.24-0.24-0.130.93-0.2-0.280.8
-0.35-0.080.54-0.640.360.77-0.48-0.250.370.38-0.330.83-0.290.87-0.220.780.57-0.360.950.830.57-0.230.38-0.26-0.4
0.09-0.08-0.260.250.64-0.190.250.150.640.650.11-0.430.62-0.39-0.04-0.39-0.260.08-0.05-0.43-0.30.220.64-0.440.05
-0.090.54-0.26-0.81-0.10.39-0.980.02-0.09-0.09-0.120.66-0.290.66-0.220.651.0-0.10.560.661.0-0.14-0.09-0.14-0.16
0.64-0.640.25-0.81-0.03-0.530.710.18-0.05-0.050.67-0.650.59-0.660.52-0.52-0.820.67-0.57-0.65-0.820.64-0.06-0.070.64
-0.180.360.64-0.1-0.030.290.13-0.181.01.0-0.15-0.110.3-0.05-0.11-0.14-0.09-0.180.4-0.11-0.070.091.0-0.11-0.13
-0.330.77-0.190.39-0.530.29-0.31-0.790.310.32-0.340.61-0.360.66-0.080.520.43-0.370.70.610.43-0.090.330.05-0.48
-0.03-0.480.25-0.980.710.13-0.31-0.090.130.14-0.01-0.610.14-0.610.16-0.65-0.98-0.03-0.51-0.61-0.970.040.130.2-0.01
0.22-0.250.150.020.18-0.18-0.79-0.09-0.2-0.210.23-0.160.28-0.19-0.06-0.060.00.31-0.22-0.16-0.01-0.05-0.21-0.290.39
-0.190.370.64-0.09-0.051.00.310.13-0.21.0-0.16-0.10.27-0.04-0.11-0.14-0.08-0.20.41-0.1-0.070.091.0-0.1-0.17
-0.190.380.65-0.09-0.051.00.320.14-0.211.0-0.16-0.10.26-0.03-0.1-0.14-0.08-0.20.4-0.1-0.070.091.0-0.1-0.19
0.99-0.330.11-0.120.67-0.15-0.34-0.010.23-0.16-0.16-0.230.6-0.240.64-0.04-0.140.97-0.21-0.23-0.150.94-0.17-0.310.84
-0.240.83-0.430.66-0.65-0.110.61-0.61-0.16-0.1-0.1-0.23-0.481.0-0.250.970.67-0.250.861.00.69-0.25-0.09-0.15-0.28
0.56-0.290.62-0.290.590.3-0.360.140.280.270.260.6-0.48-0.470.23-0.27-0.310.63-0.21-0.48-0.330.620.25-0.480.76
-0.250.87-0.390.66-0.66-0.050.66-0.61-0.19-0.04-0.03-0.241.0-0.47-0.250.960.67-0.270.891.00.68-0.24-0.03-0.16-0.3
0.68-0.22-0.04-0.220.52-0.11-0.080.16-0.06-0.11-0.10.64-0.250.23-0.25-0.17-0.20.63-0.26-0.24-0.220.66-0.11-0.060.38
-0.070.78-0.390.65-0.52-0.140.52-0.65-0.06-0.14-0.14-0.040.97-0.270.96-0.170.65-0.060.840.970.67-0.09-0.14-0.26-0.05
-0.110.57-0.261.0-0.82-0.090.43-0.980.0-0.08-0.08-0.140.67-0.310.67-0.20.65-0.130.570.670.99-0.16-0.08-0.14-0.2
0.96-0.360.08-0.10.67-0.18-0.37-0.030.31-0.2-0.20.97-0.250.63-0.270.63-0.06-0.13-0.25-0.25-0.140.89-0.21-0.290.86
-0.240.95-0.050.56-0.570.40.7-0.51-0.220.410.4-0.210.86-0.210.89-0.260.840.57-0.250.860.59-0.110.41-0.24-0.24
-0.240.83-0.430.66-0.65-0.110.61-0.61-0.16-0.1-0.1-0.231.0-0.481.0-0.240.970.67-0.250.860.69-0.25-0.09-0.15-0.28
-0.130.57-0.31.0-0.82-0.070.43-0.97-0.01-0.07-0.07-0.150.69-0.330.68-0.220.670.99-0.140.590.69-0.16-0.06-0.09-0.19
0.93-0.230.22-0.140.640.09-0.090.04-0.050.090.090.94-0.250.62-0.240.66-0.09-0.160.89-0.11-0.25-0.160.08-0.250.73
-0.20.380.64-0.09-0.061.00.330.13-0.211.01.0-0.17-0.090.25-0.03-0.11-0.14-0.08-0.210.41-0.09-0.060.08-0.1-0.19
-0.28-0.26-0.44-0.14-0.07-0.110.050.2-0.29-0.1-0.1-0.31-0.15-0.48-0.16-0.06-0.26-0.14-0.29-0.24-0.15-0.09-0.25-0.1-0.26
0.8-0.40.05-0.160.64-0.13-0.48-0.010.39-0.17-0.190.84-0.280.76-0.30.38-0.05-0.20.86-0.24-0.28-0.190.73-0.19-0.26
Click cells to compare fundamentals

Protagenic Therapeutics Account Relationship Matchups

Protagenic Therapeutics fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets879.2K11.1M8.0M4.3M3.9M3.7M
Other Current Liab513.3K520.6K620.1K541.5K487.3K462.9K
Total Current Liabilities655.2K799.5K1.1M655.3K589.7K560.2K
Total Stockholder Equity(1.1M)9.9M6.9M3.7M3.3M6.1M
Net Debt702.7K(222.7K)129.0K(1.3M)(1.2M)(1.2M)
Retained Earnings(17.7M)(22.2M)(25.8M)(30.8M)(27.7M)(29.1M)
Cash671.1K541.2K215.2K1.3M1.2M2.0M
Non Currrent Assets Other611.0296.01.8K(1.0)(0.9)(0.85)
Cash And Short Term Investments671.1K10.4M8.0M4.1M4.7M4.0M
Common Stock Shares Outstanding2.6M3.7M4.3M4.3M5.0M5.2M
Liabilities And Stockholders Equity879.2K11.1M8.0M4.3M3.9M3.7M
Other Current Assets208.2K688.7K56.9K144.0K129.6K123.1K
Other Stockholder Equity16.7M32.4M33.4M34.6M39.7M42.6M
Total Liab2.0M1.1M1.1M655.3K589.7K560.2K
Total Current Assets879.2K11.1M8.0M4.2M3.8M7.2M
Accumulated Other Comprehensive Income(171.6K)(248.3K)(676.9K)(113.5K)(102.2K)(107.3K)
Common Stock1.0K1.7K434.0444.0399.6379.62
Accounts Payable141.9K279.0K155.5K113.8K102.4K97.3K
Net Tangible Assets(210.9K)(634.4K)(1.1M)9.9M11.4M12.0M
Net Invested Capital224.1K10.3M7.3M3.7M4.2M3.5M
Net Working Capital224.1K10.3M6.9M3.5M4.1M3.4M
Capital Stock1.0K1.7K434.0444.0399.6758.8

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.